Green
and digital biomedical knowledge for interdisciplinary interfaculty
further education of students and employees in
biotechnological/biomedical companies or healthcare, with the aim of
more effective integration into the labor market
EATRIS-TRI.SI
PERMEABLE
[Raziskovalci na začetku kariere 2.1]
ŠIPK - OptMutNGS
[ŠIPK - Optimizacija odkrivanja vzročnih mutacij pri
diagnosticiranju dednih bolezni s tehnologijo sekvenciranja naslednje
generacije.]
PKP - ModGenImuno
[PKP
- Napredni napovedni modeli na osnovi genomskih in drugih molekularnih
podatkov za diagnosticiranje in spremljanje kroničnih imunskih
bolezni.]
Current
projects and collaborations: ARRS Slovenian Research Agency
J3-4497
Non-invasive multi-omics biomarkers in immune cells subtypes for
personalized medicine in childhood asthma and molecular mechanisms of
non-response to inhaled corticosteroids.
Duration:
2022
–2024. Principal
investigator: red. prof. dr. Uroš Potočnik (Medical Faculty, University of
Maribor)
L4-1843
Innovative affinity-based system for blood cell separation.
Duration:
1.7.2019
– 30.6.2022. Principal
investigator: dr. Boris Gole (Medical Faculty, University of
Maribor)
J3-9258
Molecular
genetic
biomarkers and mechanisms of unresponsiveness to biological therapy
anti-TNF in patients with chronic immune diseases Period:
1.7.2018―30.6.2021. Head: Potočnik Uroš
J3-9272
Identification of
molecular biomarkers for prognosis of clinical outcome and metastasis
in triple negative breast cancer patients. Period: 1.7.2018―30.6.2021.
Head: Takač Iztok
J1-9169
Multifunctional bioactive coatings on different substrates for
biomedical applications Period: 1.7.2018―30.6.2021. Head:
Finšgar Matjaž
J3-9289
The role of cyclic adenosine monophosphate in normal beta cell
physiology and during development of type 2 diabetes mellitus Period:
1.7.2018―30.6.2021. Head: Stožer Andraž
Current
projects and collaborations
SFRH/BD/79804/2011:
The endocannabinoid system in asthma patients and the effect of
cannabinoids in the modulation of inflammatory response (Ministry of
Science, Portugal), Principal Researcher: Uroš Potočnik
International
Inflammatory bowel disease Genetics consortium (IIBDGC)
(Slovene national consortium coordinator prof. Uroš
Potočnik).
Completed
projects and collaborations
SysPharmPedia
JTC1_99
SysPharmPedia,
“Systems pharmacology approach to difficult-to-treat
pediatric
asthma” call ERA-Net ERACoSysMed "Collaboration on systems
medicine funding to promote the implementation of systems biology
approaches in clinical research and medical practice. Period:
1.5.2016―1.5.2019. U. Potočnik coordinator for Slovenia; collaborating
with Neatherland, Spain, Germany.
J3-6785 Genetics and
pharmacogenomics of inflammatory bowel diseases and genetically related
chronic immune diseases Period: 1.7.2014―30.6.2017. Head: Potočnik
Uroš
J3-6789
“Pathogenic mechanism of the C9orf72 expanded hexanucleotide
repeat mutation in neurodegeneration; 2014-2017;
IRP-2013:
Genetics
of self-injury behavior; (Collaboration with University Clinical Center
Maribor head UKC MB T. Bunderla; head of project at MF MB U. Potočnik);
Period: 2013-2016;
IRP-2014/01-21:
Nucleotide polymorphisms in genes SDF-1ɑ, MMP7, MMP9, TIMP2, RAD18 in
MACC1 as prognostic factors for colorectal cancer (head of project at
UKC MB M. Horvat; head of project at MF MB U. Potocnik); Period:
2013-2016
IRP-2014/01-30:
Identificaition of monogenic mutations and DNA polymorphisms associated
with risk for Parkinson disease in Slovenian patients (Collaboration
with University Clinical Center Maribor head of project at UKC MB D.
Flisar, head of project at MF MB U. Potocnik); Period: 2014-2017
IRP-2014/01-29:
Identification of mutations and DNA polymorphisms in gene SCN9 in
patients with complex regional pain syndrome (Collaboration with
University Clinical Center Maribor head UKC MB D. Flisar; head of
project at MF MB U. Potočnik); Period: 2014-2017
IRP-2015:
Genetics
of chronic kidney disease; (Collaboration with University Clinical
Center Maribor head UKC MB S. Bevc; headof project at MF MB U.
Potočnik); Period: 2015-2017
IRP-2015:
Molecular
genetic biomarkers for recurrence of Head and neck cancer;
(Collaboration with University Clinical Center Maribor head UKC MB A.
Čižmarević; head of project at MF MB U. Potočnik); Period: 2015-2018
P3-0067
“Pharmacology and pharmacogenomics” (head of
project at MF
UL Mojca Kržan; prof. U. Potočnik is authorized coordinator of
Pharmacogenomics at MF MB, 2014-2017)
J3-2175
Gentski dejavniki tveganja in farmakogenomika kronično vnetne
črevesne bolezni (Slovene) Period: 1.5.2009―30.4.2012. Head: Potočnik
Uroš
J3-7141
Genetic susceptibility to gastrointestinal complex diseases and
pharmacogenomics Period: 1.9.2005―31.8.2008. Head: Potočnik
Uroš
V3-1505
Analysis and
development of rare diseases field in Slovenia Period:
1.10.2015―30.9.2017. Head: Battelino Tadej
J3-6789 Pathogenic mechanism of the C9orf72 expanded hexanucleotide
repeat mutation in neurodegeneration Period: 1.7.2014―30.6.2017. Head:
Rogelj Boris
Z3-6028
Molekularno genetske raziskave kroničnih vnetij črevesa.
Crohnova bolezen in ulcerativnikolitis (Slovene) Period:
1.2.2004―30.1.2006. Head: Ferluga Dušan
L3-5024
Incidence of erythropoietic protoporphyria and molecular
mechanism in population of Slovenia Period: 1.1.2003―31.12.2005. Head:
Krajnc Ivan
L3-5012
MOLEKULAR GENETIC PREDISPOSITION FOR DEVELOPMENT OF SOME CANCERS
Period: 1.1.2003―31.12.2005. Head: Ravnik-Glavač Metka
L3-3435
Prion diseases and their diagnostics Period: 1.7.2001―30.6.2004. Head:
Čurin Šerbec Vladka
BI-US/15-16-061
SLO-USA, (head dr. Uroš Potočnik) “Genetics and
pharmacogenomics of chronic immune diseases”, collaboration
with
New York Genome Center, USA (Dr. Tuuli Lappalainen),. Period: 2015-2016
BI-US/06-07-050
SLO-USA, Molecular genetic and pharmacogenomic markers in complex
gastrointestinal diseases (head dr. Uroš Potočnik),
collaboration with NIH-National Cancer Institute, USA (Dr. Michael
Dean). Period: 2006-2010
|
